Our study found that fecal lactoferrin levels were significantly higher in IBD patients (83.01 ± 48.54 μg/g) than in IBS patients (6.39 ± 2.69 μg/g) and healthy controls (6.80 ± 2.30 μg/g). This evidence concerns the gene LTF and irritable bowel syndrome.